Adaptin Bio (APTN) Other financing activities (2024 - 2026)
Adaptin Bio recorded quarterly Other financing activities of $121160.0 in Q1 2026, up 115.74% quarter-over-quarter from -$769621.0 in Q4 2025, and down 90.43% year-over-year from $1.3 million in Q1 2025.
Adaptin Bio's Other financing activities history runs 2 years deep, the most recent figure standing at $121160.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 90.43% year-over-year to $121160.0; the TTM figure through Mar 2026 stood at -$328336.0 (changed N/A YoY), while the FY2025 annual figure was $496864.0, up 289.67% from the prior year.
- Other financing activities came in at $121160.0 for Q1 2026 at Adaptin Bio, up from -$769621.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.3 million in Q1 2025 to a low of -$769621.0 in Q4 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121,160.00 |
| Mar 31, 2026 | 121,160.00 |
| Dec 31, 2025 | 417,038.00 |
| Dec 31, 2025 | 417,038.00 |
| Sep 30, 2025 | 320,125.00 |
| Sep 30, 2025 | 320,125.00 |
| Mar 31, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 66,366.00 |
| Dec 31, 2024 | 66,366.00 |